Epidemiologic Data of Patients in a Teaching Hospital

This study has been completed.
Sponsor:
Information provided by:
Luzerner Kantonsspital
ClinicalTrials.gov Identifier:
NCT00114335
First received: June 14, 2005
Last updated: October 9, 2008
Last verified: October 2008
  Purpose

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system

Condition
Kidney Diseases
Obesity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Impaired Renal Function in Medical Inpatients

Resource links provided by NLM:


Further study details as provided by Luzerner Kantonsspital:

Enrollment: 352
Study Start Date: May 2005
Study Completion Date: July 2005
Detailed Description:

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine

Criteria

Inclusion Criteria:

  • All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00114335

Locations
Switzerland
Kantonsspital Luzern
Luzern, LU, Switzerland, 6000
Sponsors and Collaborators
Luzerner Kantonsspital
Investigators
Principal Investigator: P Schmid, MD Kantonsspital Luzern, Hematology
Study Director: A G Fischer, MD Kantonsspital Luzern, Nephrology
Study Chair: W A Wuillemin, MD, PhD Kantonsspital Luzern, Hematology
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00114335     History of Changes
Other Study ID Numbers: LMWHplus_1
Study First Received: June 14, 2005
Last Updated: October 9, 2008
Health Authority: Switzerland: Swissmedic

Keywords provided by Luzerner Kantonsspital:
low molecular weight heparin
unfractionated heparin

Additional relevant MeSH terms:
Kidney Diseases
Obesity
Urologic Diseases
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms
Heparin, Low-Molecular-Weight
Anticoagulants
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Cardiovascular Agents

ClinicalTrials.gov processed this record on April 17, 2014